maintenance therapy: is it of value in advanced diffuse large b-cell lymphoma?
Published 6 years ago • 591 plays • Length 18:50Download video MP4
Download video MP3
Similar videos
-
9:09
debate: is maintenance therapy of value following frontline treatment for advanced dlbcl - yes
-
16:04
debate: is maintenance therapy of value following frontline treatment for advanced dlbcl - no
-
15:16
debate: how should patients with abc type dlbcl be treated today? - r-chop
-
20:48
current upfront management of dlbcl
-
22:26
key novel agents for relapsed diffuse large b-cell lymphoma
-
15:17
what is the best therapy for primary mediastinal diffuse large b-cell lymphoma
-
12:05
debate: should dlbcl patients be treated differently based on cell of origin? - yes
-
21:29
follicular lymphoma: update on upfront and maintenance therapy
-
26:29
what diffuse large b-cell lymphoma patients should receive therapy different from r-chop?
-
3:00
what is diffuse large b-cell lymphoma (dlbcl)?
-
4:40
maintenance therapy in lymphoma with dr. ann s. lacasce | everything you need to know
-
58:24
update on diffuse large b-cell lymphoma | lrf webinars
-
7:06
advanced treatment for large b-cell lymphoma: maria's story
-
21:13
how i approach the initial treatment of mantle cell lymphoma
-
25:57
what is the best approach to limited stage dlbcl? do we need radiation?
-
14:02
debate: is obinutuzumab superior to rituximab in lymphoma? - no
-
21:56
what's new in the approach to dlbcl upfront and in the relapsed setting beyond car t
-
9:30
debate: should dlbcl patients be treated differently based on cell of origin? - no
-
4:00
maintenance therapy for dlbcl